The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: metoprolol     Quarter: 2016Q3

Total Records: 1,655     Number of Pages: 83

DRUGNAME PT EventCount
METOPROLOL. 5-hydroxyindolacetic acid in urine increased 3
METOPROLOL. Abdominal mass 3
METOPROLOL. Activities of daily living impaired 3
METOPROLOL. Alanine aminotransferase increased 3
METOPROLOL. Alopecia 3
METOPROLOL. Angina pectoris 3
METOPROLOL. Arthritis 3
METOPROLOL. Aspartate aminotransferase increased 3
METOPROLOL. Benign prostatic hyperplasia 3
METOPROLOL. Blood chromogranin A increased 3
METOPROLOL. Blood potassium increased 3
METOPROLOL. Body height decreased 3
METOPROLOL. Cataract 3
METOPROLOL. Cholelithiasis 3
METOPROLOL. Circumstance or information capable of leading to medication error 3
METOPROLOL. Coagulopathy 3
METOPROLOL. Constipation 3
METOPROLOL. Coronary artery disease 3
METOPROLOL. Coronary artery stenosis 3
METOPROLOL. Death 3

Total Records: 1,655     Number of Pages: 83